ChemCom sa is a biotech startup based in Belgium, founded in 2000, with a focus on odor and taste management solutions. The company holds a unique technological platform based on proprietary licenses from Duke University, USA, specializing in human olfactory and taste receptors. With 13 employees, its offices are situated on the Medical Campus of the ULB in Brussels. ChemCom’s patented technology sets it apart in various industries including fragrance & flavor, cosmetics, pharmaceuticals, automotive, animals, water treatment, as well as feed, food, and beverage. In the fragrance and flavor industry, ChemCom offers innovative solutions for malodor and off-note counteraction, pleasant odor enhancers, development of new fragrance materials, and cost-effective formulations. Moreover, by harnessing the therapeutic characteristics of GPCRs, the company’s research also holds potential for pharmaceutical markets such as oncology, immunology, obesity, and diabetes drug discovery. ChemCom’s unique positioning in multiple industries, coupled with its groundbreaking technology, positions it as an attractive investment opportunity for venture capitalists seeking innovative biotech solutions for various sectors. With its robust technological platform and a wide range of potential applications, ChemCom presents a compelling case for potential investors looking to tap into the biotech and chemical communication sectors.
There is no investment information
No recent news or press coverage available for ChemCom sa.